Echelon lowers price target on Nubeva Technologies, keep buy rating

Echelon Wealth Partners analyst Gianluca Tucci thinks there is a ton of upside to be had in Nubeva Technologies (Nubeva Technologies Stock Quote, Chart TSXV:NBVA), but the analyts’s most recent report has him tempering expectations slightly.

In a research update to clients Wednesday, Tucci maintained his “Speculative Buy” rating, but lowered his one-year price target on Nubeva from $1.50 to $1.20, implying a return of 243 per cent at the time of publication.

The analyst explained his reasoning.

“We are bullish on the company’s pivot to focus on Prisms ahead of StratusEdge,” Tucci said. “We believe that this will lead to incremental longer term shareholder gains. However, we have tempered our near term momentum expectations as we wait for the prisms to gain customer trials and more importantly commercial adoption. In the context of a TSXV that declined 35% for 2018 and with an applicable ~20% discount rate within DCF valuations, we are reducing our PT by 20% to C$1.20 reflecting timing considerations and looking for visibility on a ramp in commercial revenues.”

Tucci thinks Nubeva will post Adjusted EBITDA of negative $1.4-million (all figures USD) on revenue of $2.4-million in fiscal 2019. He expects those numbers will improve to EBITDA of negative $200,000 on a topline of $1.9-million the following year.

Tagged with: nbva
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

BCE upgraded to “Buy” at TD

TD Cowen analyst Vince Valentini says the recent pullback in BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE) shares… [Read More]

2 days ago

This analyst just upgraded Versabank to “Buy”

Roth Capital Partners analyst Craig Irwin says VersaBank’s (VBNK Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) early commercial rollout of… [Read More]

2 days ago

This analyst just raised his price target on Rocket Lab USA

Roth Capital Partners analyst Suji Desilva says Rocket Lab USA’s (Rocket Lab USA Stock Quote, Chart, News, Analysts, Financials NASDAQ:RKLB)… [Read More]

3 days ago

Why this analyst just chopped his price target on Medicenna Therapeutics

Research Capital analyst Andre Uddin says Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) has upcoming clinical… [Read More]

3 days ago

Firan Technology: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley says Firan Technology Group’s (Firan Technology Group Stock Quote, Chart, News, Analysts, Financials TSX:FTG) new… [Read More]

3 days ago

Magellan Aerospace is still undervalued, this fund manager says

LionGuard Capital Management CEO and CIO Andrey Omelchak says Magellan Aerospace (Magellan Aerospcace Stock Quote, Chart, News, Analysts, Financials TSX:MAL)… [Read More]

5 days ago